| Financial Year |
March 31 2023 |
| Monetary Funds |
43,130,270.82 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,970,487.19 |
| Accounts Receivable |
42,902,046.43 |
| Advances to Suppliers |
10,481,200.94 |
| Other Receivables |
7,306,361.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,698,135.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,594,034.96 |
| Other Current Assets |
10,851,804.93 |
| Total Current Assets |
146,934,342.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
49,811,336.47 |
| Long-term Equity Investment |
979,338.52 |
| Investment Properties |
-- |
| Fixed Assetes |
122,883,284.46 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,751,473.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,069,380.09 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
12,035,431.52 |
| Sub-Total of Non-Current Assets |
221,782,688.09 |
| Total Assets |
368,717,030.93 |
| Short-Term Loans |
78,016,900.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
159,068.39 |
| Accounts Payable |
89,074,316.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,928,423.69 |
| Taxes Payable |
990,534.33 |
| Interest Payable |
-- |
| Dividend Payable |
886,872.66 |
| Other payables |
18,674,588.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,351,064.16 |
| Other Current Liabilities |
133,194.56 |
| Sub-Total of Current Liabilities |
214,352,663.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
954,785.80 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,647,568.49 |
| Total Liabilities |
279,000,231.96 |
| Paid-In Capital(Or Share Stock) |
285,380,986.00 |
| Capital Surplus |
1,223,185,367.21 |
| Surplus Reserve |
33,592,108.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,527,432,687.66 |
| Minority Stockholder's Interest |
73,571,120.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,145,678.10 |
| Owner's Equity（Stockholder's Equity） |
89,716,798.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
368,717,030.93 |
